Characterization of the Human Cytomegalovirus UL105 Gene and Identification of the Putative Helicase Protein

We have characterized the transcription unit for the human cytomegalovirus UL105 gene and identified its putative protein product. The UL105 gene product is proposed to mediate helicase activity in the assembled helicase–primase complex. The two other putative proteins in this complex are the gene p...

Full description

Saved in:
Bibliographic Details
Published inVirology (New York, N.Y.) Vol. 220; no. 1; pp. 251 - 255
Main Authors SMITH, JEAN A., JAIRATH, SANJU, CRUTE, JAMES J., PARI, GREGORY S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.1996
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We have characterized the transcription unit for the human cytomegalovirus UL105 gene and identified its putative protein product. The UL105 gene product is proposed to mediate helicase activity in the assembled helicase–primase complex. The two other putative proteins in this complex are the gene products of UL102 (primase-associated factor) and UL70 (primase). Using Northern blot analysis we have determined that the UL105 transcript is a 3.4-kb message that can be detected as early as 24 hr postinfection in the presence of phosphonoformic acid but not in the presence of cycloheximide. Subsequent primer-extension analysis showed a transcriptional start site upstream of a consensus TATA sequence and just downstream of a CCAAT box sequence motif. In addition, we have identified an infected cell protein with an approximate molecular weight (Mr) of 110 kDa using anti-peptide antiserum. This same antiserum detected proteins of the sameMras those produced from two expression systems where the protein from the 981-amino-acid UL105 open reading frame was overexpressed, suggesting that the ATG located at nt 151,850 of the genomic sequence is utilized in the context of the virus genome.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0042-6822
1096-0341
DOI:10.1006/viro.1996.0310